论文部分内容阅读
据多国利阿唑研究组报道，Janssen公司的利阿吐（liarozole）对治疗恶性前列腺癌有效，且有助于维持病人的生活质量。为了比较本品与环丙孕酮（Cyprotero）的疗效，研究者进行了一项开放性Ⅲ期临床研究，321例转移性前列腺癌病人经一线endocrine治疗后进入本研究。病人随机接受
According to the multi-national liarozole study group, Janssen’s liarozole is effective in the treatment of malignant prostate cancer and helps to maintain the patient’s quality of life. To compare the efficacy of this product with cyproterone (Cyprotero), the investigators conducted an open phase III clinical study of 321 patients with metastatic prostate cancer who entered the study after first-line endocrine therapy. Patient randomized